According to Lifecore Biomedical's latest financial reports the company's current EPS (TTM) is -$3.34. In 2022 the company made an earnings per share (EPS) of -$2.50 a decrease over its 2021 EPS that were of -$1.91.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.34 | 33.31% |
2022 | -$2.50 | 31.06% |
2021 | -$1.91 | 9.92% |
2020 | -$1.74 | 371.1% |
2019 | -$0.37 | -146.7% |
2018 | $0.79 | 150.96% |
2017 | $0.31 | -171.58% |
2016 | -$0.44 | -192.77% |
2015 | $0.47 | -23.31% |
2014 | $0.62 | -7.88% |
2013 | $0.67 | -9.22% |
2012 | $0.74 | 289.13% |
2011 | $0.19 | 11.14% |
2010 | $0.17 | -39.17% |
2009 | $0.28 | -37.54% |
2008 | $0.45 | -67.39% |
2007 | $1.38 | 236.13% |
2006 | $0.41 | 71.07% |
2005 | $0.24 | 41.18% |
2004 | $0.17 | 1600% |
2003 | $0.010000 | -109.09% |
2002 | -$0.11 | -76.6% |
2001 | -$0.47 |